INSIGHTS ON CLINICAL TRIAL DESIGN

• Can Your Trial Payment Approach Stand Up To Regulatory Scrutiny?

  Fragmented trial payment systems create compliance, ethical, and operational risks. Aligning payments with regulations and ethics improves transparency, reduces burden, and supports audits and participation.

• Best Practices For Operationalizing Global, Early-Phase Oncology Trials

  In this presentation, industry experts will share real-world lessons learned from managing global early-phase oncology trials.

• Stop Guessing On Trial Feasibility: Simulating Patient Recruitment With AI

  Simulate enrollment, endpoints, and criteria with integrated data and synthetic populations to test protocol feasibility early — refining design and reducing recruitment and regulatory risks.

• Elevating The Site Voice

  A decentralized trial can be daunting for sites, but Medidata offers solutions to help site staff, sponsors, and patients move smoothly through the clinical trial process.

• Your Biggest Unblinding Risk? Inexperienced Staff

  4/28/2026

  Protect study integrity by closing the gaps in IRT workflows. Learn why rushed communication and training lapses lead to accidental unblinding and how to safeguard your clinical data.

• IRT: A New Approach To Meeting The Needs Of Early Phase Trials

  8/14/2025

  As early phase clinical trials become more sophisticated, sponsors are now leveraging flexible IRT solutions to replace error-prone manual processes and gain greater control and efficiency.

• The True Science Behind eCOA, Shaped By Patient And Site Insights

  6/17/2026

   

  This webinar brings together patients, sites, and eCOA science to dismantle the researcher-subject hierarchy and replace it with a collaborative model.

   

• 5 Questions To Ask Before Selecting A Randomization Partner

  5/12/2026

  Choose the right IRT partner for complex master protocols. Learn how adaptive randomisation expertise and flexible technology reduce disruption and keep trials execution-ready.

• AI's Bottleneck In Clinical Trials Moved, And Most People Missed It

  7/20/2026

  AI has accelerated drug discovery, but the real bottleneck is now clinical trial operations. Explore why regulatory success depends on auditable data governance, not model speed.